Retrieving Articles by ID GET
The Product Content API GET /v1/content/articles/{articleId} endpoint returns the article matching the article id provided. The article id is a required parameter for the endpoint. For the Product Content articles endpoint, a subscribed article from any product may be returned. In general, they all have some similar sections, such as metadata, toc, sections and ancillary. Within these sections there may be some small variations in what is included. The JSON response below shows a sample response from DynaMed. See the /articles/id endpoint guides for Dynamic Health, Consumer Health, NAH Reference Center or DynaMed Decisions for more details on what to expect.
Basic Retrieving of an Article by ID
To Get a Basic Article (example):
Gather the following information for the request:
- An access token. Please see Using the Client Credentials Grant for further information.
- The article ID to retrieve.
Request
GET https://apis.ebsco.com/medsapi-product-content/v1/content/articles/dm:t1644526395752The request above is for DynaMed article ID dm:t1644526395752. This response shows a DynaMed response. While mostly similar to other product article JSON, there are small differences between products in terms of which fields are populated and which ones are added. Consult the article/ID guides listed above for details.
Response
{
"id": "dm:t1644526395752",
"title": "Bleeding Disorders - Approach to the Patient",
"slug": "/approach-to/bleeding-disorders-approach-to-the-patient",
"links": [
{
"rel": "self",
"href": "https://apis.ebsco.com/medsapi-product-content/v1/content/articles/dm:t1644526395752"
}
],
"metadata": {
"DC.rights.owner": "(C) Copyright 2026",
"copyright": "(C) Copyright 2026",
"DC.Type": "topic",
"DC.Identifier": "GUID-F9BA81DC-1C48-4EF4-B884-81EFD311136A",
"DC.Date.Revised": "",
"DC.Title": "Bleeding Disorders - Approach to the Patient",
"description": "Bleeding disorders are conditions in which the ability to form or maintain a clot is impaired, resulting in abnormal bleeding.",
"abstract": "Bleeding disorders are conditions in which the ability to form or maintain a clot is impaired, resulting in abnormal bleeding.",
"DC.Date.Created": "",
"DC.Coverage": [
"",
""
],
"DC.IsPartOf": "GUID-C5A4C0C4-1758-4D15-8DE9-9F4F2A119656",
"DC.Language": "en",
"DC.Format": "XHTML",
"DC.Relation": [
"article://T1635174066130"
]
},
"toc": [
{
"title": "Overview and Recommendations",
"anchor": "GUID-8AEC8EDF-26EC-4350-A44C-EB90988563BF",
"children": [
{
"title": "Evaluation",
"anchor": "EVALUATION"
},
{
"title": "Management",
"anchor": "MANAGEMENT"
}
]
},
...
],
"sections": [
{
"anchor": "GUID-8AEC8EDF-26EC-4350-A44C-EB90988563BF",
"title": "Overview and Recommendations",
"content": "<div class=\"body\"><p class=\"p\">Bleeding disorders are conditions in which the ability to form or maintain a clot is impaired, resulting in abnormal bleeding of varying severity, depending on the underlying cause. </p>\n</div>",
"children": [
{
"anchor": "EVALUATION",
"title": "Evaluation",
"content": "<div class=\"body\"><ul class=\"ul\"><li class=\"li\">Take a detailed <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#HISTORY\" target=\"_blank\">history</a> of possible medical conditions that may cause bleeding such as cancer, liver disease, and kidney disease, <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#MEDICATION_HISTORY\" target=\"_blank\">current medications</a>, <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_PVY_533_KTB\" target=\"_blank\">past bruising/bleeding episodes</a>, and <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#FAMILY_HISTORY\" target=\"_blank\">family history of bleeding and medical history</a>.</li>\n<li class=\"li\">To appropriately evaluate patients presenting with bleeding, it is important to:<ul class=\"ul\"><li class=\"li\">Rule out bleeding in keeping with trauma or surgery<ul class=\"ul\"><li class=\"li\">Bleeding related to accidental trauma more commonly involves distal upper and lower extremities and is consistent with a history of the causative event.</li>\n<li class=\"li\">Bleeding related to nonaccidental trauma (such as physical abuse) is characterized by atypical pattern or unusual appearance that is inconsistent with accidental trauma or a history of potential medical causative event such as surgery.</li>\n</ul>\n</li>\n<li class=\"li\">Rule out <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_V1N_WBL_XSB\" target=\"_blank\">medications and supplements</a> as a possible cause of bleeding; improvement in bleeding after discontinuation of the drug is confirmatory</li>\n</ul>\n</li>\n<li class=\"li\">Perform a physical examination including cutaneous signs of bleeding. Findings consistent with a bleeding disorder include: <ul class=\"ul\"><li class=\"li\">≥ 5 bruises (each greater than 1 cm in size) occurring simultaneously on exposed areas</li>\n<li class=\"li\">Bruising on the trunk and other areas (not limited to extremities)</li>\n</ul>\n</li>\n<li class=\"li\">Evaluation of <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_X1H_ZVG_DTB\" target=\"_blank\">bleeding patterns</a> and patient and family medical history should guide work-up.<ul class=\"ul\"><li class=\"li\">For example:<ul class=\"ul\"><li class=\"li\">Presentation in childhood is more characteristic of inherited disorders; severe inherited bleeding disorders commonly present during infancy or early childhood</li>\n<li class=\"li\">If bleeding presents at an older age or in adulthood or there is change in bleeding tendency, an acquired cause should be considered</li>\n<li class=\"li\">Patients with vascular abnormalities may present with purpuric rash that is nonblanching (does not disappear when pressure is applied)</li>\n<li class=\"li\">Patients with connective tissue disorders such as Ehlers-Danlos syndrome may present with mucocutaneous bleeding, bruising around the eyes, petechiae, and spontaneous ecchymoses recurring in the same location and associated with hemosiderin deposition</li>\n<li class=\"li\">Patients with defects in primary hemostasis often present with mucocutaneous bleeding, including petechiae, epistaxis, gingival bleeding, gastrointestinal, or genitourinary bleeding but deep tissue bleeding (joint and muscle bleeds) is infrequent</li>\n<li class=\"li\">In patients with defects in secondary hemostasis, deep tissue bleeding is common and may occur spontaneously in patients with severe coagulation factor deficiencies or occur upon injury if the deficiency is moderate or mild</li>\n<li class=\"li\">Patients with defects in tertiary hemostasis may present with a history of delayed bleeding or rebleeding after initial clot formation post trauma</li>\n</ul>\n</li>\n<li class=\"li\">When assessing bruising and/or bleeding, consider using a <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_PVY_533_KTB__LI_YPF_TF4_HTB\" target=\"_blank\">bleeding assessment tool</a> for standardizing bleeding history information obtained from patients and to accurately record severity and frequency of bleeding.</li>\n</ul>\n</li>\n<li class=\"li\">Consider <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_PFL_NXK_XSB\" target=\"_blank\">initial blood tests</a> in patients with easy bruising to detect underlying cause, including:<ul class=\"ul\"><li class=\"li\"><a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_GTK_RWZ_WRB\" target=\"_blank\">Complete blood count</a>, especially platelet count to detect presence of thrombocytopenia</li>\n<li class=\"li\"><a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_Z2V_W3Z_YSB\" target=\"_blank\">Coagulation screening tests</a> to determine coagulation abnormalities including:<ul class=\"ul\"><li class=\"li\">Prothrombin time (PT)/INR</li>\n<li class=\"li\">Activated partial thromboplastin time (aPTT)</li>\n<li class=\"li\">Clauss fibrinogen assay</li>\n<li class=\"li\">Thrombin time</li>\n</ul>\n</li>\n<li class=\"li\"><a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_YVL_GM1_XRB\" target=\"_blank\">Peripheral blood smear</a> to detect abnormal platelet size, which can suggest certain inherited platelet disorders and hematologic malignancies</li>\n<li class=\"li\">Liver function tests and kidney function tests</li>\n</ul>\n</li>\n<li class=\"li\">Consider the additional following tests only if results of the initial blood tests point in the direction of <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_BZF_NXK_XSB\" target=\"_blank\">further work-up</a>. Additional testing may involve:<ul class=\"ul\"><li class=\"li\">Platelet function testing (<a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_WYV_WXK_XSB\" target=\"_blank\">light transmission aggregometry [LTA]</a>) to determine presence of platelet function disorders in patients with abnormal platelet size on a peripheral blood smear</li>\n<li class=\"li\">Testing for <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_DL2_YQQ_BTB\" target=\"_blank\">von Willebrand disease</a></li>\n<li class=\"li\"><a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_Z2V_W3Z_YSB__LI_KGP_4YL_CTB\" target=\"_blank\">Mixing study</a> to detect coagulation factor inhibitors</li>\n<li class=\"li\"><a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_Z2V_W3Z_YSB__LI_TRL_PFM_CTB\" target=\"_blank\">Coagulation factor activity assays</a> to detect deficiencies in coagulation factors</li>\n</ul>\n</li>\n</ul>\n</div>"
},
...
]
},
...
],
"tablesContent": {
"TOPIC_PFL_NXK_XSB__TABLE_UNB_TGZ_QSB": "<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" class=\"table standAlone\" frame=\"border\" id=\"TOPIC_PFL_NXK_XSB__TABLE_UNB_TGZ_QSB\" rules=\"all\" summary=\"\"><caption><span class=\"tablecap\">Table 1: Select Possible Causes of Bleeding According to Platelet Count and Coagulation Screen Findings</span></caption><thead class=\"thead\" style=\"text-align:left;\"><tr class=\"row\"><th class=\"entry cellrowborder\" id=\"D30E6740\">Platelet Count</th>\n<th class=\"entry cellrowborder\" id=\"D30E6742\">Prothrombin Time/INR*</th>\n<th class=\"entry cellrowborder\" id=\"D30E6744\">Activated Partial Thromboplastin Time*</th>\n<th class=\"entry cellrowborder\" id=\"D30E6746\">Thrombin Time*</th>\n<th class=\"entry cellrowborder\" id=\"D30E6748\">Fibrinogen Level*</th>\n<th class=\"entry cellrowborder\" id=\"D30E6750\">Possible Causes</th>\n</tr>\n</thead>\n<tbody class=\"tbody\"><tr class=\"row\"><td class=\"entry cellrowborder\" headers=\"d30e6740 \">Low</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6742 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6744 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6746 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6748 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6750 \">Thrombocytopenia</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\" headers=\"d30e6740 \">Normal </td>\n<td class=\"entry cellrowborder\" headers=\"d30e6742 \">Prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6744 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6746 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6748 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6750 \">Factor VII deficiency or inhibitor</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\" headers=\"d30e6740 \">Normal </td>\n<td class=\"entry cellrowborder\" headers=\"d30e6742 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6744 \">Prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6746 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6748 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6750 \">Factor VIII, IX, or XI deficiency or inhibitor</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\" headers=\"d30e6740 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6742 \">Prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6744 \">Prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6746 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6748 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6750 \"><ul class=\"ul\"><li class=\"li\">Prothrombin, factor V, or factor X deficiency or inhibitor</li>\n<li class=\"li\">Liver disease (may also present with thrombocytopenia) </li>\n<li class=\"li\">Vitamin K deficiency</li>\n<li class=\"li\">Factor V Short </li>\n</ul>\n</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\" headers=\"d30e6740 \">Normal </td>\n<td class=\"entry cellrowborder\" headers=\"d30e6742 \">Normal or Prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6744 \">Normal or Prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6746 \">Prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6748 \">Reduced</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6750 \"><ul class=\"ul\"><li class=\"li\">Hypofibrinogenemia</li>\n<li class=\"li\">Dysfibrinogenemia</li>\n</ul>\n</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\" headers=\"d30e6740 \">Normal </td>\n<td class=\"entry cellrowborder\" headers=\"d30e6742 \">Infinitely prolonged </td>\n<td class=\"entry cellrowborder\" headers=\"d30e6744 \">Infinitely prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6746 \">Infinitely prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6748 \">Undetectable </td>\n<td class=\"entry cellrowborder\" headers=\"d30e6750 \">Afibrinogenemia</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\" headers=\"d30e6740 \">Low </td>\n<td class=\"entry cellrowborder\" headers=\"d30e6742 \">Normal or prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6744 \">Normal or prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6746 \">Normal or prolonged</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6748 \">Normal or decreased</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6750 \">Disseminated intravascular coagulation </td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\" headers=\"d30e6740 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6742 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6744 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6746 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6748 \">Normal</td>\n<td class=\"entry cellrowborder\" headers=\"d30e6750 \"><ul class=\"ul\"><li class=\"li\">Factor XIII deficiency or inhibitor</li>\n<li class=\"li\">Fibrinolytic defects </li>\n<li class=\"li\">von Willebrand disease (affecting collagen binding function or mild type form)</li>\n<li class=\"li\">Disorder of vascular hemostasis</li>\n<li class=\"li\">Combination of mild deficiency of coagulation factors, VWF, and undetected IPFD</li>\n</ul>\n</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder tfooter\" colspan=\"6\" headers=\"d30e6740 d30e6742 d30e6744 d30e6746 d30e6748 d30e6750 \"><p class=\"p\">Abbreviations: IPFD, inherited platelet function disorder; VWF, von Willebrand factor. </p>\n<p class=\"p\">* See <a class=\"link internal jump-link\" data-location=\"internal\" data-transform=\"link\" data-type=\"jump\" href=\"#TOPIC_Z2V_W3Z_YSB\" target=\"_blank\">Coagulation studies</a> for information on additional factors that may influence coagulation screening test results.</p>\n<p class=\"p\">Reference - <div data-title=\"Int J Lab Hematol 2018 May;40 Suppl 1:6\" data-transform=\"full-text-container\" data-value=\"29741250\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/29741250\">PubMed Abstract</a></div>, <div data-title=\"Haemophilia 2020 Nov;26(6):946\" data-transform=\"full-text-container\" data-value=\"33094877\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/33094877\">PubMed Abstract</a></div>, <div data-title=\"J Thromb Haemost 2016 Aug;14(8):1507\" data-transform=\"full-text-container\" data-value=\"27208505\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/27208505\">PubMed Abstract</a><a href=\"https://onlinelibrary.wiley.com/doi/10.1111/jth.13368\">Public Full Text</a></div>, <div data-title=\"Semin Thromb Hemost 2012 Jul;38(5):447\" data-transform=\"full-text-container\" data-value=\"22740184\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/22740184\">PubMed Abstract</a></div>, <div data-title=\"Am Fam Physician 2016 Feb 15;93(4):279\" data-transform=\"full-text-container\" data-value=\"26926815\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/26926815\">PubMed Abstract</a><a href=\"https://www.aafp.org/afp/2016/0215/p279.html\">Public Full Text</a></div>, <div data-title=\"Blood 2018 Feb 22;131(8):845\" data-transform=\"full-text-container\" data-value=\"29255070\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/29255070\">PubMed Abstract</a><a href=\"https://ashpublications.org/blood/article/131/8/845/104418/How-I-treat-disseminated-intravascular-coagulation\">Public Full Text</a></div>, <div data-title=\"Hematology Am Soc Hematol Educ Program 2015;2015:243\" data-transform=\"full-text-container\" data-value=\"26637729\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/26637729\">PubMed Abstract</a></div>.</p>\n</td>\n</tr>\n</tbody>\n<colgroup><col style=\"width:16.666666666666664%\"/><col style=\"width:16.666666666666664%\"/><col style=\"width:16.666666666666664%\"/><col style=\"width:16.666666666666664%\"/><col style=\"width:16.666666666666664%\"/><col style=\"width:16.666666666666664%\"/></colgroup></table>",
"GUID-53940050-6923-43FD-838F-8AA13FBF5253__TABLE_AAA_AA5_4A4": "<table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" class=\"table\" frame=\"border\" id=\"GUID-53940050-6923-43FD-838F-8AA13FBF5253__TABLE_AAA_AA5_4A4\" rules=\"all\" summary=\"\"><tbody class=\"tbody\"><tr class=\"row\"><td class=\"entry cellrowborder\">Topic Editors define the scope and focus of each topic by formulating a set of clinical questions and suggesting important guidelines, clinical trials, and other data to be addressed within each topic. Topic Editors also serve as consultants for the internal DynaMed Editorial Team during the writing and editing process, and review the final topic drafts prior to publication.</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\">Section Editors have similar responsibilities to Topic Editors but have a broader role that includes the review of multiple topics, oversight of Topic Editors, and systematic surveillance of the medical literature.</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\">Recommendations Editors provide explicit review of Overview and Recommendations sections to ensure that all recommendations are sound, supported, and evidence-based. This process is described in \"Synthesized Recommendation Grading.\"</td>\n</tr>\n<tr class=\"row\"><td class=\"entry cellrowborder\">Deputy Editors oversee DynaMed internal publishing groups. Each is responsible for all content published within that group, including supervising topic development at all stages of the writing and editing process, final review of all topics prior to publication, and direction of an internal team.</td>\n</tr>\n</tbody>\n<colgroup><col style=\"width:100%\"/></colgroup></table>"
},
"ancillary": {
"pubType": {
"id": "approachto"
},
"contributors": {
"authors": [],
"editors": [
{
"degrees": "MD",
"firstName": "Parul",
"lastName": "Bhargava",
"label": "Topic Editor ",
"affiliationText": "Professor of Clinical Laboratory Medicine, University of California San Francisco, California, United States; Senior Medical Director, University of California San Francisco, California, United States",
"conflictsText": "Dr. Bhargava declares no relevant financial or non-financial relationships with ineligible companies or other parties."
},
...
],
"reviewers": []
},
"relatedLinks": [
"T1613074818048"
],
"multimedia": [
{
"mediaType": "image",
"content": [
{
"id": "i1632271897943",
"title": "Coagulation cascade",
"format": "svg",
"copyright": "Copyright ©2021 EBSCO Information Services.",
"mediaProvider": "EBSCO",
"mediaHost": "Cloudinary",
"description": "Intrinsic, extrinsic, and common pathways of the coagulation cascade.",
"publicId": "EBSCOHealth/CCMS/Dynamed/images/I1632271897943",
"links": [
{
"rel": "external",
"href": "https://media.ebsco.healthcare/eis-live/image/authenticated/v1/EBSCOHealth/CCMS/Dynamed/images/I1632271897943.svg?__cld_token__=exp=1773342116~hmac=84004e9944ef54ee32d8a55a9a9146363912405fbe543429a97d8113b96dedce"
}
],
"contentLocations": [
{
"rel": "external",
"href": "https://apis.ebsco.com/medsapi-product-content/v1/content/articles/dm:t1628861590937"
},
...
]
},
...
]
},
{
"mediaType": "algorithm",
"content": [
{
"id": "a1667485795879",
"title": "Spontaneous bleeding and bruising evaluation algorithm",
"format": "svg",
"copyright": "Copyright ©2025 EBSCO Information Services.",
"mediaProvider": "EBSCO",
"mediaHost": "Cloudinary",
"description": "Adapted from Hematol Oncol Clin North Am. 2021 Dec;35(6):1039-1049, Haemophilia. 2020 Nov;26(6):946-957, Int J Lab Hematol. 2018 May;40 Suppl 1:6-14, Br J Hosp Med (Lond). 2017 Oct 2;78(10):C147-C151, Am Fam Physician. 2016 Feb 15;93(4):279-286, J Am Board Fam Med. 2014 Jul-Aug;27(4):549-64. Last reviewed 2025.",
"publicId": "EBSCOHealth/CCMS/Dynamed/images/A1667485795879",
"links": [
{
"rel": "external",
"href": "https://media.ebsco.healthcare/eis-live/image/authenticated/v1/EBSCOHealth/CCMS/Dynamed/images/A1667485795879.svg?__cld_token__=exp=1773342116~hmac=8752fae03d4611d662b6d2370dff17b596363e97ebf40190fb0917ece24cfdda"
}
],
"contentLocations": [
{
"rel": "external",
"href": "https://apis.ebsco.com/medsapi-product-content/v1/content/articles/dm:t1644526395752"
},
...
]
}
]
}
],
"tables": [
{
"id": "TOPIC_PFL_NXK_XSB__TABLE_UNB_TGZ_QSB",
"title": "Table 1:",
"caption": "Select Possible Causes of Bleeding According to Platelet Count and Coagulation Screen Findings",
"standAlone": true,
"parentSection": "TOPIC_PFL_NXK_XSB"
},
...
],
"headerMetadata": {
"tags": [],
"routes": [],
"classes": [],
"boxedWarnings": []
},
"referenceLinks": [
{
"description": "<li class=\"li\"><span class=\"data-wrapper\" property=\"citationMeta\"><span class=\"data\" property=\"Source\" value=\"PubMed\"></span><span class=\"data\" property=\"SourceID\" value=\"29741250\"></span><span class=\"data\" property=\"JournalName\" value=\"International journal of laboratory hematology\"></span><span class=\"data\" property=\"JournalNameAbbrev\" value=\"Int J Lab Hematol\"></span><span class=\"data\" property=\"PublicationDate\" value=\"20180501\"></span><span class=\"data\" property=\"Volume\" value=\"40 Suppl 1\"></span><span class=\"data\" property=\"Issue\" value=\"\"></span><span class=\"data\" property=\"Pagination\" value=\"6-14\"></span><span class=\"data\" property=\"StartPage\" value=\"6\"></span></span>Hayward CPM. How I investigate for bleeding disorders. <div data-title=\"Int J Lab Hematol. 2018 May;40 Suppl 1:6-14\" data-transform=\"full-text-container\" data-value=\"29741250\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/29741250\">PubMed Abstract</a></div>.</li>",
"anchor": "GUID-1385345E-5E52-4DF3-9CE0-6436CAF18643__HAYWARD2018"
},
...
],
"consensusDetails": []
}
}Additional fields may be returned in the metadata.
Media within Articles
Access to Multimedia Assets
Article responses may include references to multimedia assets within the multimedia section of the response payload.
Each multimedia entry can include the following metadata:
- Title – The name or caption associated with the media asset
- Copyright – Copyright attribution information
- Media URL – A link to the associated image or video asset
Media URL Behavior
- The media URL provides access to a full-resolution image or video.
- The URL is temporary and valid for 24 hours from the time the article response is generated.
- Clients must not cache the URL.
Access and Refresh
- If access to the media asset is required after the 24-hour validity period, the client must re-request the article through the API to obtain a new media URL.
- No additional authentication is required to retrieve the media asset once the URL has been issued.
Specifying Image and Video Image Sizes
Links to images of varying sizes may be returned in the article response. To specify the image size, add one or more imageSize query parameters to the call. small (200w), medium (500w) and large (1000w) image sizes are supported. Also, the full image size is supported and is the default if no image size was specified. A still image of the video (aka thumbnail or poster) can also be returned with the video. To specify the size, add one or more posterSize parameters to the call. Small, medium, large and full sized images of the video will be returned. To distinguish the video and video link in the response, a type parameter is added and is set to "poster". No poster is returned unless posterSize is provided.
| Parameter Name | Description |
|---|---|
| secure | Set to true to return secure https URLs for media links. (True is the default, except for Dynamic Health articles) |
| imageSize | Returns the requested size(s): small, medium, large, full. |
| posterSize | Returns the requested size(s) for poster of the video links: small, medium, large or full. |
| convertSvg | Return images and algorithms that are originally in svg format as png format. |
Image Link Section when imageSize is Requested
When imageSize is requested, the image link will look the same as in the above response, but with the addition of imageSize.
"links": [
{
"rel": "external",
"imageSize": "small",
"href": "https://media.ebsco.healthcare/eis-live/image/authenticated/t_s200/f_auto/v1/EBSCOHealth/CCMS/i508496.png?cld_token__=exp=1589557523~hmac=39e61c4969ae0fc2034b65fa3096d7582ead7a487cd5ff89301e2f873cb2d5f1"
}
]Video Link Section when posterSize is Requested
"links": [
{
"rel": "external",
"href": "https://media.ebsco.healthcare/eis-live/video/authenticated/v1/EBSCOHealth/CCMS/Dynamed/videos/V123456.mp4"
},
{
"rel": "external",
"posterSize": "large",
"type": "poster",
"href": "https://media.ebsco.healthcare/eis-live/video/authenticated/t_s1000/f_jpg/v1/EBSCOHealth/CCMS/Dynamed/videos/V123456.jpg"
}
]Error Response Codes
The Product Code articles endpoint can return one of the error response codes. Note that consumers of this endpoint should consider retrying if receiving a 429 response code. That status code can be returned if too many requests are received within a very short period of time.
Updated 11 days ago